Stocks and Investing Stocks and Investing
Thu, March 30, 2023
Wed, March 29, 2023
Tue, March 28, 2023
Mon, March 27, 2023

Reni Benjamin Maintained (BCAB) at Buy with Decreased Target to $12 on, Mar 27th, 2023


Published on 2024-10-28 02:25:57 - WOPRAI, Reni Benjamin
  Print publication without navigation


Reni Benjamin of JMP Securities, Maintained "BioAtla, Inc." (BCAB) at Buy with Decreased Target from $17 to $12 on, Mar 27th, 2023.

Reni has made no other calls on BCAB in the last 4 months.



There are 3 other peers that have a rating on BCAB. Out of the 3 peers that are also analyzing BCAB, 1 agrees with Reni's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Reiterated at Hold and Held Target at $8 on, Friday, March 24th, 2023


These are the ratings of the 2 analyists that currently disagree with Reni


  • Arthur He of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $17 on, Friday, March 24th, 2023
  • Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $25 on, Friday, March 24th, 2023